VALN CIK: 1836564

Valneva SE

  • France
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions EUR
FY21:
76.9
FY22:
−245
FY23:
−203
FY24:
−67.2
FY25:
−52.9
Change from FY21 to FY25
millions EUR
FY21:
−93.1
FY22:
−29.1
FY23:
−20.6
FY24:
76.9
FY25:
−1.71
Change from FY21 to FY25
millions EUR
FY21:
155
FY22:
215
FY23:
63.1
FY24:
30.7
FY25:
−0.62
millions EUR
FY21:
138
FY22:
−59.3
FY23:
−160
FY24:
40.4
FY25:
−55.2
(positive)
Change from FY21 to FY25
millions EUR
FY21:
−15.3
FY22:
−275
FY23:
−217
FY24:
−81.1
FY25:
−57.3

All amounts in millions EUR Data source:SEC EDGAR